Unsymmetrically substituted benzimidazolium based Silver(I)-N-heterocyclic carbene complexes: Synthesis,characterization and in vitro anticancer study against human breast cancer and colon cancer

The promising biomedical applications of silver complexes stimulated the researchers to test these compounds against cancer. The present research work was designed to achieve this goal. In this work, a series of 5-methyl benzimidazole based N-Heterocyclic carbene ligands and respective silver(I) complexes were synthesized and tested on cancer cell lines to assess their anticancer activity. Unsymmetrically substituted benzimidazole was found unique in its reactivity and generation of a single product during NHC ligand formation was only possible after two successive alkylations with same alkyl halide. The corresponding Ag(I)-NHC adducts were obtained by in situ deprotonation of the NHC ligands. Synthesized compounds were characterized by various physcio-chemical and spectroscopic methods. Single crystal X-ray diffraction study of complex 7 revealed its mononuclear structure. Preliminary in vitro anticancer study of azolium salts and respective Ag(I)-NHC complexes against human breast cancer (MDA-MB-231), colon cancer (HCT-116) and normal endothelial cells (EA.hy926) cells revealed that all the compounds are more cytotoxic to cancer cells than normal cells and the complexes are relatively more potent compared to the corresponding NHC ligands. It was found that increased chain length and presence of methyl substituent on benzimidazole ring enhance the biopotency of Ag(I)-NHC complexes. The synthesized compounds were further studied for pro-apoptotic mechanism of action via Rhodamine 123 test. The tested compounds were found to induce apoptosis via extrinsic mitochondrial pathway.     

Palladium(II) N-heterocyclic carbene complexes: synthesis,structures and cytotoxicity potential studies against breast cancer cell line

Abstract

Mononuclear trans-Pd(II)–NHC complexes (where NHC?=?N-heterocyclic carbene) bearing asymmetrically substituted NHC-ligand have been synthesized via transmetalation reaction between Ag(I)–NHC complexes and [Pd(NCCH₃)₂Cl₂]. The NHC precursors are accessible in two steps by N-n-alkyl reactions of benzimidazole. The resultant benzimidazolium salts were deprotonated with Ag₂O by in situ deprotonation to facilitate the formation of mononuclear Ag(I)–NHC complexes. Single-crystal structural study for Pd(II)–NHC shows that the palladium(II) ion exhibits a square-planar geometry of two NHC ligands and two chloride ions. The cytotoxicity study was investigated against breast cancer cell line (MCF-7). The Ag(I)–NHC complexes exhibit better activities than their corresponding Pd(II)–NHC complexes, whereas all benzimidazolium salts are inactive toward MCF-7 cancer cell line.     

Synthesis,spectroscopic characterization,antineoplastic, in vitro-cytotoxic,and antibacterial activities of mononuclear ruthenium(II) complexes

The synthesis, antineoplastic, cytotoxic, and antibacterial activities of Ru(II) complexes derived from quinazoline and thiosemicarbazone ligands are reported. These complexes have been prepared and characterized by UV-Vis, IR, ¹H-NMR, FAB-mass spectroscopy, and elemental analysis. The ligands and resulting complexes were subjected to in vivo antineoplastic activity against a transplantable murine tumor cell line Ehrlich ascites carcinoma (EAC) and in vitro cytotoxic activity against human cancer cell line Molt 4/C₈, CEM, and murine tumor cell line L 1210. The ruthenium complexes show promising biological activity especially in decreasing tumor volume and viable ascitic cell counts. These complexes prolonged the life span of mice bearing EAC tumors by 10–52%. In vitro evaluation of these ruthenium complexes revealed cytotoxic activity from 0.29 to 2.9?µmol?L^?1 against Molt 4/C₈, 0.22 to 2.1?µmol?L^?1 against CEM and 0.42 to 4.7?µmol?L^?1 against L1210 cell proliferation, depending on the nature of the compound. The metal complexes are more active than the parent ligand and exhibit mild to moderate antibacterial activity.     

New Ni(II) complexes involving symmetrical bidentate N,O-donor Schiff base ligands: synthesis at ambient temperature,crystal structures,electrochemical study,antioxidant and cytotoxic activities

A new series of Ni(II) complexes, [Ni(L¹)₂] (1), [Ni(L²)₂] (2), [Ni(L³)₂] (3), and [Ni(L⁴)₂] (4), were synthesized at ambient temperature. The bidentate Schiff base ligands HL^1?4 have been obtained by the condensation reaction of 2-hydroxybenzaldehyde, 5-bromo-2-hydroxybenzaldehyde, 3-methoxy-2-hydroxy-benzaldehyde, and 4-methoxy-2-hydroxy-benzaldehyde, respectively, with 2-methoxyethylamine. The newly synthesized complexes were characterized by elemental analyses, FT-IR and UV–vis spectroscopy. The crystal structures of mononuclear Ni(II) complexes 2 and 3 were determined by the single-crystal X-ray diffraction technique. Electrochemical properties of the complexes were investigated in acetonitrile. The antioxidant properties of the Schiff base ligands and complexes were evaluated by two in vitro tests, DPPH radical scavenging and reducing power. The compounds were screened for their in vitro anticancer potential using gastric cancer cell lines by MTT assay. All ligands and complexes showed considerable cytotoxic activity against cancer cell lines (IC₅₀ = 0.2516–5.468 μg·mL^?1). The most promising result was achieved for complex 1 with the best IC₅₀ value of 0.2516 μg·mL^?1. It was found that the proliferation rate of MKN-45 cells decreased after treatment with the complexes in a dose-dependent way.     

Design,synthesis, molecular docking,and biological studies of novel phytoestrogen-tanaproget hybrids

A diverse range of novel and highly functionalized flavonoid-based tanaproget hybrids were synthesized and evaluated in vitro for their antimicrobial and antiproliferative activities. Novel products were synthesized in good yields (81–95%) under Pd-catalyzed reaction from bromo flavones and tanaproget boronic acids within 18–20 min at 60 °C. Bioassay results exhibited excellent activities against both hormone-dependent and hormone-independent human breast cancer cells (MCF-7, MDA-MB-231, DU-145, PC-3, and HeLa). Among them, compounds 4e, 9a, 9c, 9e, 9 g, 9 h, 9 m, and 9n displayed excellent activity. Compounds 4d, 4o, and 9o were found equally potent against C. albicans compared to fluconazole. Compound 5c showed better antibacterial activity against S. aureus. Compounds 5a, 9i, 9o, and 10c have shown admirable antibacterial activity against E. coli.     

Synthesis and antimicrobial studies of 1-methyl-2-dimethylaminoethyl-substituted benzimidazolium salts and N-heterocyclic carbene–silver complexes

The synthesis and antimicrobial studies of 1-methyl-2-dimethylaminoethyl-substituted carbene precursors and silver complexes are reported. The carbene precursors (1a–d) have been prepared from 1-methyl-2-dimethylaminoethyl-substituted benzimidazole and various alkyl halides. The silver–NHC complexes (2a–d) were synthesized from the benzimidazolium salts and Ag₂O in dichloromethane at room temperature. The new compounds were characterized by ¹H NMR, ¹³C NMR, FT-IR, and elemental analyses. The new carbene precursors and Ag-complexes were tested for their in vitro antimicrobial activity against a variety of Gram-positive and Gram-negative bacteria, as well as for their antifungal activities against Candida albicans and Candida tropicalis.     

Synthesis,characterization, antitumor,and cytotoxic activity of mononuclear Ru(II) complexes

In the search for antitumor active metal complexes several ruthenium complexes have been reported to be promising. A series of mononuclear Ru(II) complexes, [Ru(T)₂(S)]²⁺, where T?=?2,2′-bipyridine/1,10-phenanthroline and S?=?CH₃-bitsz, Cl-bitsz, Br-bitsz, tmtsz, dmtsz, have been prepared and characterized by UV-Vis, IR, ¹H-NMR, FAB-mass spectroscopy, and elemental analysis. The complexes were subjected to in vivo anticancer activity against a transplantable murine tumor cell line Ehrlich's ascitic carcinoma (EAC) and in vitro cytotoxic activity against human cancer cell line Molt 4/C₈, CEM, and murine tumor cell line L1210. Ruthenium complexes showed promising biological activity especially in decreasing tumor volume and viable ascitic cell counts. Treatment with these complexes prolonged the life span of EAC-tumor-bearing mice by 10–48%. In vitro evaluation of these ruthenium complexes revealed cytotoxic activity from 0.21 to 24?µmol?L^?1 against Molt 4/C₈, 0.16–19?µmol?L^?1 against CEM, and 0.75–32?µmol?L^?1 against L1210 cell proliferation, depending on the nature of the compound.     

Synthesis,characterization, and evaluation of silver(I) complexes with mixed-ligands of thiosemicarbazones and diphenyl(p-tolyl)phosphine as biological agents

Five new silver(I) complexes were synthesized with mixed ligands of thiosemicarbazone derivatives and diphenyl(p-tolyl)phosphine in search of new biologically active compounds. A CHN elemental analysis, powder X-ray diffraction (PXRD) data and several spectroscopic techniques such as Fourier-transform infrared spectroscopy, energy-dispersive X-ray, ¹H, ¹³C, and ³¹P{¹H} NMR were performed to elucidate the structure of these complexes. Elemental analysis suggested that the stoichiometry of the complexes formed by the reaction of silver nitrate with thiosemicarbazone in the presence of (p-tolyl)PPh₂ was indeed 1:2:1 molar ratio. The silver ions were discovered to be coordinated to the sulfur of thiosemicarbazone and phosphorus of (p-tolyl)PPh₂, having a tetrahedral geometry based on the spectroscopic data obtained. The PXRD patterns were studied to see the degree of crystallinity of the complexes. The in vitro antiproliferative activity of these complexes was investigated toward the MDA-MB-231 and MCF-7 breast cancer cell lines, as well as the HT-29 colon cancer cell line, which yielded IC₅₀ values in low micromolar range. The antiplasmodial activity of these complexes was also examined against chloroquine-resistant Plasmodium falciparum parasite which demonstrated good activity and further tested for their selectivity index.     

Asymmetric N-heterocyclic carbene benzimidazolium salts and their silver(I) complexes: potential as ionic liquid crystals

The synthesis and characterisation of a homologous series of monodentate benzimidazolium salts, 1–4 and their mononuclear silver(I)–NHC (where NHC = N-heterocyclic carbene) complexes, 5–8, are reported. The benzimidazolium salts were prepared from the N-alkylation of 1-methyl-benzimidazole with alkyl halides of varying carbon chain lengths. The mono silver(I)-NHC complexes, 5–8, were prepared by the reaction of the benzimidazolium salts with Ag₂O. All the synthesised compounds were fully characterised by ¹H-nuclear magnetic resonance (¹H-NMR), ¹³C-NMR and fourier-transform infrared (FTIR) spectroscopy. The molecular structures of compounds 3·PF₆, 4·PF₆, 7 and 8 were elucidated through single-crystal X-ray diffraction analyses. We postulate that the attachment of long alkyl chains to the heterocyclic core of 1-methyl benzimidazole could induce mesophase formation. The liquid crystalline behaviour of the benzimidazolium salts was investigated by polarised optical microscope and differential scanning calorimetry. Salts 3 and 4 were found to be thermotropic liquid crystals which exhibited a smectic A phase. However, upon complexation with silver(I) ions, all the Ag(I)–NHC complexes are found to be non-mesogenic.     

Palladium(II)-N-heterocyclic carbene-catalyzed direct C2- or C5-arylation of thiazoles with aryl bromides

Herein we report, a series of new benzimidazolium chlorides as N-heterocyclic carbene (NHC) ligand and their corresponding palladium(II)-NHC complexes with the general formula [PdCl₂(NHC)₂] were synthesized. All new compounds were characterized by ¹H NMR, ¹³C NMR, IR spectroscopy and elemental analysis techniques. The catalytic activity of palladium(II)-NHC complexes was investigated in the direct C2- or C5-arylation of thiazoles with aryl bromides in presence of palladium(II)-NHC at 150?°C for 1?h. These complexes exhibited the good catalytic performance for the direct arylation of thiazoles. The arylation of thiazoles regioselectively produced C2- or C5-arylated thiazoles in moderate to high yields.     

两个有机锡杂环羧酸酯配合物的合成、结构及抗癌活性

合成了2个有机锡杂环羧酸酯配合物：二（邻溴苄基）锡二（2-吡啶甲酸）酯（1）和三（2-甲基-2-苯基丙基）锡3-吲哚丁酸酯（2）。通过元素分析、红外光谱、核磁共振谱（¹H、¹³C和¹¹⁹Sn）、X射线衍射、热重分析进行了表征,用X射线单晶衍射方法测定了配合物的晶体结构,进行了配合物的结构量子化学从头计算和体外抗癌活性研究。结果显示：配合物均为单锡核分子,锡原子分别为六配位的畸变八面体构型和四配位的畸变四面体构型;配合物对人肝癌细胞（HUH7）、人肺癌细胞（A549）、人表皮癌细胞（A431）、人结肠癌细胞（HCT-116）和乳腺癌细胞（MDA-MB-231）的抑制活性均比临床使用的顺铂强。     

Inhibiting the growth of tumor cells by ruthenium(II) complexes [Ru(phen)2L] (L = o-TFMPIP and p-CPIP) through DNA-binding

[Ru(phen)₂o-TFPIP]²⁺ (1) and [Ru(phen)₂p-CPIP]²⁺ (2) have been synthesized and demonstrated to inhibit the growth of tumor cells. The inhibitory activities (IC₅₀) of 1 against the growth of C6, MDA-MB-231 and HepG2 cells were about 24.5, 36.7, and 36.1 μM, respectively. Studies show that both complexes bind to CT-DNA, explained by using density functional theory calculations. The LogP calculated for 1 and 2 are ?0.4859 and ?1.279, respectively. These complexes, especially 1, can be used as promising inhibitors in chemotherapy, and their DNA-binding behaviors play a key role.     

124I Radiolabeling of a AuIII-NHC Complex for In Vivo Biodistribution Studies

Au^III complexes with N-heterocyclic carbene (NHC) ligands have shown remarkable potential as anticancer agents, yet their fate in vivo has not been thoroughly examined and understood. Reported herein is the synthesis of new Au^III-NHC complexes by direct oxidation with radioactive [¹²⁴I]I₂ as a valuable strategy to monitor the in vivo biodistribution of this class of compounds using positron emission tomography (PET). While in vitro analyses provide direct evidence for the importance of Au^III-to-Au^I reduction to achieve full anticancer activity, in vivo studies reveal that a fraction of the Au^III-NHC prodrug is not immediately reduced after administration but able to reach the major organs before metabolic activation.     

含硅二烃基锡(Ⅳ)水杨醛缩氨基硫脲席夫碱配合物的合成、结构及抗癌活性

合成了11个含硅二烃基锡的水杨醛缩氨基硫脲席夫碱配合物R(Me3SiCH2)SnL(R=Me3SiCH2或Ph,Cy;H2L=水杨醛缩氨基硫脲席夫碱),并通过1H NMR、13C NMR、IR、元素分析和X射线单晶衍射对目标化合物结构进行了表征。结果表明,水杨醛缩氨基硫脲席夫碱作为三齿双阴离子配体,通过酚氧、亚胺氮和硫醇硫与锡(Ⅳ)配位,形成了中心锡原子为五配位的五元杂环与六元杂环的并联结构。生物活性试验的初步结果显示,该类化合物对人体乳腺癌细胞MDA-MB-231和MCF-7具有较好的体外抗癌活性。     

Non-symmetrically p-nitrobenzyl- and p-cyanobenzyl-substituted N-heterocyclic carbene-silver(I) complexes: synthesis,characterization and antibacterial studies

Various nitro/nitrile-functionalized benzimidazol-2-ylidene carbene complexes of silver(I) (7a–d and 11a–d) were synthesized by combination of 1-allyl/1-isopropyl/1-sec-butyl/1-isopentyl-3-(nitro/cyano-benzyl)-3H-benzimidazol-1-ium hexafluorophosphate (6a–d and 10a–d) with silver(I) oxide in acetonitrile. The compounds were characterized by ¹H, ¹³C NMR, FT-IR, mass spectrometry, and elemental analysis. Additionally, the in vitro antibacterial activity of the N-heterocyclic carbene (NHC) precursors (6a–d and 10a–d) and their corresponding NHC-silver(I) complexes (7a–d and 11a–d) were investigated against Gram-positive bacteria Staphylococcus aureus and Gram-negative bacteria Escherichia coli using the qualitative Kirby-Bauer disk diffusion method. All the NHC-silver(I) complexes exhibited medium-to-high antibacterial activity with areas of clearance ranging from 12 mm to 21 mm, while the NHC precursors were inactive against both strains of bacteria.     

Synthesis,in vitro cytotoxicity,and molecular docking study of novel 3,4-dihydroisoquinolin-1(2H)-one based piperlongumine analogues

With the aim of expanding the scope of SAR on piperlongumine (PL), a naturally occurring anticancer molecule, we have designed a novel hybrid molecule bearing 3,4-dihydroisoquinolin-1(2H)-one and trans-cinnamic acids. The structure, based on hybridization strategy, is used for hybridization of naturally occurring scaffolds. We have synthesized 14 hybrid molecules by coupling 3,4-dihydroisoquinolin-1(2H)-one core with cinnamic acids using the mix anhydride approach. The newly synthesized inhibitors were evaluated for cell viability against breast cancer MCF-7 and cervical cancer HeLa cell lines. Furthermore, the active compounds were screened for their potential in breast cancer MDA-MB-231, cervical cancer C33A cell lines, prostate cancer DU-145, PC-3, and normal VERO cells. From the series, compound 10g was seen to inhibit MCF-7 cell growth significantly with GI₅₀ < 0.1 μM along with growth inhibition in MDA-MB-231 (GI₅₀ = 20 μM) and C33A (GI₅₀ = 3.2 μM). While the inhibitor 10i inhibits MCF-7 breast cancer cell growth GI₅₀ = 3.42 μM along with inhibition of cell growth in MDA-MB-231 (GI₅₀ = 30 μM), HeLa (GI₅₀ = 7.67 μM), C33A (GI₅₀ = 13 μM), DU-145 (GI₅₀ = 6.45 μM), PC-3 (GI₅₀ = 8.68 μM), and VERO (GI₅₀ = 2.93 μM), respectively. Furthermore, molecular docking study demonstrated these compounds could bind tightly to the colchicine domain of tubulin through a network of favorable steric and electrostatic interactions and thus act as a tubulin polymerization inhibitor.     

Synthesis,characterization, and in vitro antibacterial and antifungal studies of tin(IV) thiohydrazide complexes

Reaction of tin dichloride and tin tetrachloride with cyclohexylamine-N-thiohydrazide (ChaThz) [L¹] and 1,3-propanediamine-N-thiohydrazide (PdaThz) [L²] results in [Sn(ChaThz)₂] (1), Sn(ChaThz)₂Cl₂] (2), [Sn(PdaThz)₂] (3), and [Sn(PdaThz)₂Cl₂] (4), in which the thiohydrazide coordinates to tin through imine nitrogen and thioamide sulfur. The ratio metal?:?ligand was 1?:?2 for all complexes. The tin(IV) thiohydrazide complexes were characterized by elemental analysis, IR, UV-Vis, ¹H-NMR, ¹¹⁹Sn NMR, and mass spectral studies. Using the disc diffusion method, the ligands and metal complexes were screened for in vitro antibacterial activities against four pathogenic bacteria, Escherichia coli, Staphylococcus aureus, P. aeruginosa, and Bacillus cereus and for antifungal activities against Aspergillus flavus, A. carbonarius, A. niger, and A. fumigatus. While the tin(IV) complexes exhibited moderate antifungal activities, their parent ligands showed much higher and long-lasting broad spectrum of bioactivity against fungal growth. This was particularly the case for L¹ whose fungal inhibitory activity by the end of the experimental period was comparable and, for the most part, more pronounced than that of AmB. This higher activity of L¹ was maintained specifically against S. Aureus but in general, bacteria were more susceptible to complexes than ligands.     

New salen-type manganese(III) Schiff base complexes derived from meso-1,2-diphenyl-1,2-ethylenediamine: In vitro anticancer activity,mechanism of action,and molecular docking studies

Four new manganese(III) Schiff base complexes (1–4) were synthesized and characterized. The complexes have general formula [MnClL^x] in which L represents a Schiff base ligand derived from condensation of meso-1,2-diphenyl-1,2-ethylenediamine with salicylaldehyde or its 3-OMe-, 5-Br-, or 5-OMe-derivatives (x = 1–4, respectively). The crystal structure of [MnClL¹] (1) was characterized by X-ray crystallography. The in vitro anticancer activity of these complexes was evaluated by MTT and apoptosis assays against human breast (MCF-7) and liver (Hep G2) cancer cells. The complexes exhibited considerable antiproliferative activity against both cell lines (IC₅₀ = 10.8–21.02 μM) comparable to cis-platin, except 4 (MCF-7). The highest activity was found for 1 with IC₅₀ values of 13.62 μM (MCF-7) and 10.8 μM (Hep G2). Flow cytometry experiments showed that 1 induced apoptosis on MCF-7 tumor cell line. Docking simulations using AUTODOCK were also carried out. The results showed that all complexes fitted into the minor groove region of DNA.     

Triorganotin(IV) complexes with substituted benzeneseleninic acids: syntheses,characterization, crystal structures,and antitumor activity

Nine new organotin(IV) selenites have been prepared by the reaction of 2-methylbenzeneseleninic acid, 2-methoxybenzeneseleninic acid, 4-isopropylbenzeneseleninic acid, and the corresponding triorganotin(IV) chloride with sodium ethoxide in methanol. The complexes have been characterized by elemental analysis, FT-IR, (¹H, ¹³C, and ¹¹⁹Sn) NMR spectroscopy, and thermogravimetric analysis. Except for 3, 6, and 9, all of the complexes were also characterized by X-ray crystallography diffraction analyses. The structural analyses reveal that 1, 2, 4, 5, 7, and 8 exhibit 1-D infinite chain structures which are generated by bidentate oxygen atoms and five-coordinated tin. Complex 5 forms a 2-D organotin framework linked by intermolecular C–H?···?O interactions. Additionally, 1 and 2 were tested for antitumor activity in vitro.     

Phytochemical profiling,antioxidant, enzyme inhibition and cytotoxic potential of Bougainvillea glabra flowers

Abstract

In this study, phytochemical composition, antioxidant, enzyme inhibition and cytotoxic activities of methanol and dichloromethane (DCM) extracts of Bougainvillea glabra (B. glabra) flowers were investigated. Methanol extract was found to have higher total bioactive contents and UHPLC-MS analysis of methanol extract revealed the presence of well-known phenolic and flavonoid compounds. Antioxidant activities were performed by radical scavenging (DPPH and ABTS), reducing power (FRAP and CUPRAC), phosphomolybdenum (TAC) and metal chelating assays. From our result, we observed that methanol extract had many antioxidant compounds. The DCM extract exhibited higher cholinesterases and α-glucosidase enzyme inhibition, while methanol extract showed significant urease inhibition. Both extracts exhibited strong to moderate cytotoxicity against MCF-7, MDA-MB-231, CaSki, DU-145 and SW-480 cancer cells with IC₅₀ values ranging from 88.49 to 304.7 µg/mL. The findings showed the B. glabra to possess considerable antioxidant, enzyme inhibition and cytotoxic potentials and therefore has potential to discover novel bioactive molecules.